Evaluation of commutability of control materials

被引:11
作者
Brion, E
Lessinger, JM
Gould, N
Leyendecker, J
Férard, G
机构
[1] Univ Strasbourg 1, UFR Sci Pharmaceut, Lab Biochim Appl, F-67400 Illkirch Graffenstaden, France
[2] European Support Ctr, Illkirch Graffenstaden, France
关键词
control materials; commutability;
D O I
10.1515/CCLM.2002.108
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The commutability of 13 control materials was evaluated by performing parallel measurements on two different analysers: a Synchron CX-5 Delta from Beckman-Coulter and a Vitros 950 from Ortho-Clinical Diagnostics. Twenty three clinical chemistry analytes (substrates, electrolytes and enzymatic activities) were determined in plasma from 15 different patients in order to define intermethod relationship for each analyte. The relationship observed for each control material was compared to those obtained for patients specimens. The results show that commutability depends both on the tested analyte and on the control material. No totally commutable material has been found for the whole set of tested parameters. Most control materials were commutable for inorganic phosphate, glucose, chloride, triglycerides, alanine aminotransferase, amylase and gamma-glutamyltransferase, but less than a quarter of control materials were commutable for sodium, calcium, creatinine, alkaline phosphatase and lipase. Seven materials were commutable for more than half of the analytes, whereas five control materials were commutable for less than a quarter of these analytes. We propose to verify the commutability of materials before their use in an external quality control assessement.
引用
收藏
页码:625 / 630
页数:6
相关论文
共 11 条
  • [1] Cattozzo G, 1997, EUR J CLIN CHEM CLIN, V35, P387
  • [2] Myoglobin and creatine kinase isoenzyme MB mass assays: intermethod behaviour of patient sera and commercially available control materials
    Cattozzo, G
    Franzini, C
    d'Eril, GVM
    [J]. CLINICA CHIMICA ACTA, 2001, 303 (1-2) : 55 - 60
  • [3] *EUR COMM STAND CE, 2000, 17577 ISO DIS ISO CE
  • [4] FASCE CF, 1973, CLIN CHEM, V19, P5
  • [5] Férard G, 2002, ANN BIOL CLIN-PARIS, V60, P9
  • [6] FERRERO CA, 1995, CLIN CHEM, V41, P575
  • [7] KROLL MH, 1989, CLIN CHEM, V35, P1523
  • [8] LESSINGER JM, 1995, ANN BIOL CLIN-PARIS, V53, P147
  • [9] FACTITIOUSLY LOW URATE RECOVERIES IN CONTROL SERA WITH THE BECKMAN-SYNCHRON SYSTEMS
    LIBEER, JC
    HAMERS, N
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1994, 54 (06) : 485 - 486
  • [10] Commutability and traceability:: their repercussions on analytical bias and inaccuracy
    Ricós, C
    Juvany, R
    Simón, M
    Hernández, A
    Alvarez, V
    Jiménez, CV
    Minchinela, J
    Perich, C
    [J]. CLINICA CHIMICA ACTA, 1999, 280 (1-2) : 135 - 145